Factors affecting mortality risk in pediatric head injuries in Africa: a meta-analysis

Kwadwo Darko1, Bernice Limann2, Pearl Ohenewaa Tenkorang3

  • 1Department of Neurosurgery, Korle Bu Teaching Hospital, Accra, Ghana.

Insights

Road traffic accidents (RTAs) and seizures are key risk factors for mortality in pediatric head injuries in low- and middle-income countries. Early preventive measures, like improved infrastructure, can reduce pediatric TBI mortality.

Area of Science:

  • Global Health
  • Pediatric Traumatology
  • Epidemiology

Background:

  • Traumatic brain injury (TBI) mortality is significantly higher in low- and middle-income countries (LMICs) compared to high-income nations.
  • Pediatric head injuries represent a substantial public health concern in LMICs, necessitating a deeper understanding of mortality risk factors.

Purpose of the Study:

  • To systematically review and assess factors influencing mortality risk in pediatric patients with head injuries in LMICs.
  • To identify specific causes and clinical presentations associated with increased mortality in pediatric TBI cases.

Main Methods:

  • A comprehensive systematic review was conducted following PRISMA guidelines.
  • Literature search was performed across PubMed, Google Scholar, and Web of Science databases.
  • Data from 42 studies across 12 African countries were analyzed.

Main Results:

  • The study included 42 studies from 12 African countries, analyzing pediatric head injuries.
  • Road traffic accidents (RTAs) were the leading cause of injury (56.0-69.2%), followed by falls (21.0-37.9%).
  • The overall mortality rate was 19%, with RTAs identified as a significant risk factor (RR: 43.7).

Conclusions:

  • Road traffic accidents and seizures at presentation are identified as critical risk factors for mortality in pediatric head injuries.
  • Implementing early preventive strategies, including infrastructure enhancements for road safety, is recommended to mitigate pediatric TBI mortality.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.3K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
258
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
195
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214